We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Garlic Found to Kill Brain Cancer Cells

By Biotechdaily staff writers
Posted on 11 Sep 2007
For the first time, organosulfur substances found in garlic have been shown to be effective against glioblastoma, a type of brain tumor equivalent to a death sentence within a short period after diagnosis.

Swapan Ray, Ph.D., a neurosciences/neurology associate professor at the Medical University of South Carolina (MUSC; Charleston, SC, USA), and researchers evaluated three pure organosulfur compounds (diallyl sulfide [DAS], 4,4'-diaminodiphenyl sulfone [DADS], and diallyl trisulfide [DATS]) from garlic and the interaction with human glioblastoma cells. More...
All three compounds demonstrated efficacy in eradicating brain cancer cells, but DATS was shown to be the most effective. The study will be published in the September 2007 issue of the American Cancer Society's journal, Cancer.

Cancer cells have a high metabolism and require a lot of energy for rapid growth. In this study, garlic compounds generated reactive oxygen species in brain cancer cells, in effect, gorging them to death with activation of multiple death cascades.

"This research highlights the great promise of plant-originated compounds as natural medicine for controlling the malignant growth of human brain tumor cells,” Dr. Ray said. "More studies are needed in animal models of brain tumors before application of this therapeutic strategy to brain tumor patients.”

The investigators are optimistic about the possible applications of their discovery to patient care. "Our basic studies will eventually be translated to clinics for patient care. We may have to wait several years before its application to humans, but the significance of this discovery is enormous,” noted Naren Banik, Ph.D., a MUSC neurosciences/neurology professor and co- investigator of the study. "The benefits from this research to brain cancer patients will bring great satisfaction to researchers and clinicians who are trying to find a successful treatment for this devastating cancer.”

Garlic-derived organosulfur compounds are small molecules that would not necessarily require complex methods of delivery for treating brain tumor patients, according to the researchers, and their natural origin is probably better for the human body than synthetic treatment alternatives.

To take advantage of any potential anti-cancer benefits from garlic now, certain rules apply. Dr. Ray noted that to cut and peel a piece of fresh garlic and let it sit for 15 minutes before eating or cooking it. This time allows for the release of an enzyme (allinase) that produces the anti-cancer compounds. However, eating too much garlic can cause diarrhea, allergies, and internal bleeding, so it is important to monitor garlic consumption.


Related Links:
Medical University of South Carolina

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.